LATS1 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) LncRNA HCG11 mediated by METTL14 inhibits the growth of lung adenocarcinoma via IGF2BP2/LATS1Biochemical and biophysical research communicationsNovember 26, 2021Mao J, Qiu H, Guo L.

(4) Programmable Synthetic Protein Circuits for the Identification and Suppression of Hepatocellular CarcinomaMolecular therapy oncolyticsJune 26, 2020Han X, Yang J, Zeng F, Weng J, Zhang Y, Peng Q, Shen L, Ding S, Liu K, Gao Y.

(5) Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance Induced by Membranous/Cytoplasmic/Nuclear Translocation of Epidermal Growth Factor ReceptorJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerOctober 1, 2019Rong X, Liang Y, Han Q, Zhao Y, Jiang G, Zhang X, Lin X, Liu Y, Zhang Y, Han X, et al.

(7) FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxisFASEB journal : official publication of the Federation of American Societies for Experimental BiologyFebruary 1, 2018Lachowski D, Cortes E, Robinson B, Rice A, Rombouts K, Del Río Hernández AE.

(8) A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo PathwayCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacologyJanuary 1, 2018Bao L, Yuan L, Li P, Bu Q, Guo A, Zhang H, Cui N, Liu B.

(9) WWC3 inhibits epithelial-mesenchymal transition of lung cancer by activating Hippo-YAP signalingOncoTargets and therapyJanuary 1, 2018Han Q, Kremerskothen J, Lin X, Zhang X, Rong X, Zhang D, Wang E.

(12) Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancerTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineJuly 1, 2014Lin XY, Zhang XP, Wu JH, Qiu XS, Wang EH.

LATS1 shRNA Plasmid (h)